{"id":23609,"date":"2000-02-21T12:51:17","date_gmt":"2000-02-21T18:51:17","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=23609"},"modified":"2018-04-14T01:59:05","modified_gmt":"2018-04-14T06:59:05","slug":"23609","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/pt\/23609\/","title":{"rendered":"Not\u00edcias e notas sobre sa\u00fade animal de 21 de fevereiro de 2000 - edi\u00e7\u00e3o especial"},"content":{"rendered":"<p>SPECIAL EDITION<br \/>\nBrakke Consulting&rsquo;s <br \/>\nAnimal Health News &amp; Notes for February 21, 2000<br \/>\nCopyright &copy; Brakke Consulting, Inc.<\/p>\n<p>(note: the regular edition of Brakke Consulting Animal Health News &amp; Notes will be published on February 25.)<\/p>\n<p>Company News Releases<br \/>\n&bull;&nbsp;Merck and Aventis, joint parent companies of Merial, announced that effective February 21, 2000, Alan Reade will assume the position of executive chairman of Merial.&nbsp; The announcement was made on February 18, 2000.&nbsp; Reade was formerly the president and CEO of Rhone-Poulenc Agro for North American Operations, and is currently the leader of the Aventis CropScience post-merger integration process.&nbsp; In order to ensure a smooth transition John Preston, the previous executive chairman of Merial, and Louis Champel, the previous CEO, will serve as consultants to Merial and Alan Reade for a limited period of time.<\/p>\n<p>*********************************************************************<\/p>\n<p>Brakke Consulting Viewpoint<\/p>\n<p>Merck and Rhone Poulenc announced last week that they have completed the first phase of the Merial organization that was developed with the forming of Merial in 1997.&nbsp; A press release was made by Merial in London on February 18, 2000 indicating that Alan Reade would become the Executive Chairman of Merial effective February 21, 2000.&nbsp; The release further indicates that Dr. Preston and Mr. Champel will serve as consultants to Merial and Mr. Reade for a limited period of time.<\/p>\n<p>The timing and content of this announcement apparently caught many Merial employees and the industry by surprise.&nbsp; It had been assumed and anticipated that Louis Champel would become the Executive Chairman and that Dr. Preston would return to Merck at the end of the first two years.&nbsp; It is not clear what the underlying implications are for this abrupt change.&nbsp; We will be watching closely to see how this change affects Merial and others in the industry.<\/p>\n<p>[Ron Brakke]<\/p>\n<p>********************************************************<br \/>\nThis electronic newsletter is the sole property of Brakke Consulting, Inc.<br \/>\nAny use of the contents herein should be approved by and appropriately attributed to Brakke Consulting, Inc.<\/p>\n<p>For more information about Brakke Consulting&rsquo;s services and syndicated studies, visit our website at <a href=\"https:\/\/brakkeconsulting.com\">www.brakkeconsulting.com<\/a> &lt;<a href=\"https:\/\/brakkeconsulting.com\">https:\/\/brakkeconsulting.com<\/a>&gt;.<\/p>\n<p>If this email was forwarded to you and you would like to be added to the circulation list, please send an email to <a href=\"mailto:info@brakkeconsulting.com\">info@brakkeconsulting.com<\/a> with &ldquo;add&rdquo; typed in the subject line, and your name and company affiliation in the body of the message, and you will be added to the mailing list.&nbsp; If you would like for us to remove your name from the circulation list, please send an email to <a href=\"mailto:info@brakkeconsulting.com\">info@brakkeconsulting.com<\/a> with &ldquo;remove&rdquo; and your name typed in the subject line.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>EDI\u00c7\u00c3O ESPECIAL Not\u00edcias e notas sobre sa\u00fade animal da Brakke Consulting de 21 de fevereiro de 2000 Copyright \u00a9 Brakke Consulting, Inc. (observa\u00e7\u00e3o: a edi\u00e7\u00e3o regular das Not\u00edcias e notas sobre sa\u00fade animal da Brakke Consulting ser\u00e1 publicada em 25 de fevereiro.) Comunicados \u00e0 imprensa da empresa \u2022 A Merck e a Aventis, empresas controladoras conjuntas da Merial, anunciaram que, a partir de 21 de fevereiro de 2000, Alan Reade assumir\u00e1 o cargo de presidente executivo da Merial. O an\u00fancio foi feito em 18 de fevereiro de 2000. Reade foi presidente e CEO da Rhone-Poulenc Agro para opera\u00e7\u00f5es na Am\u00e9rica do Norte e atualmente \u00e9 o l\u00edder do processo de integra\u00e7\u00e3o p\u00f3s-fus\u00e3o da Aventis CropScience. Para garantir uma transi\u00e7\u00e3o tranquila, John Preston, ex-presidente executivo da Merial, e Louis Champel, ex-CEO, atuar\u00e3o como consultores da Merial e de Alan Reade por um per\u00edodo limitado. ************************************************************************* Brakke Consulting Viewpoint Merck e Rhone Poulenc anunciaram na semana passada que conclu\u00edram a primeira fase da organiza\u00e7\u00e3o Merial, desenvolvida com a forma\u00e7\u00e3o da Merial em 1997. Um comunicado \u00e0 imprensa foi divulgado pela Merial em Londres em 18 de fevereiro de 2000, indicando que Alan Reade se tornaria o Presidente Executivo da Merial a partir de 21 de fevereiro de 2000. O comunicado indica ainda que o Dr. Preston e o Sr. Champel atuar\u00e3o como consultores da Merial e do Sr. Reade por um per\u00edodo limitado.<\/p>\n<div class=\"view-full-post\"><a href=\"https:\/\/brakkeconsulting.com\/pt\/23609\/\" class=\"view-full-post-btn\">Ver postagem completa<\/a><\/div>\n<p>;<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":["post-23609","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>News from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/pt\/23609\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"SPECIAL EDITION Brakke Consulting&rsquo;s Animal Health News &amp; Notes for February 21, 2000 Copyright &copy; Brakke Consulting, Inc. (note: the regular edition of Brakke Consulting Animal Health News &amp; Notes will be published on February 25.) Company News Releases &bull;&nbsp;Merck and Aventis, joint parent companies of Merial, announced that effective February 21, 2000, Alan Reade will assume the position of executive chairman of Merial.&nbsp; The announcement was made on February 18, 2000.&nbsp; Reade was formerly the president and CEO of Rhone-Poulenc Agro for North American Operations, and is currently the leader of the Aventis CropScience post-merger integration process.&nbsp; In order to ensure a smooth transition John Preston, the previous executive chairman of Merial, and Louis Champel, the previous CEO, will serve as consultants to Merial and Alan Reade for a limited period of time. ********************************************************************* Brakke Consulting Viewpoint Merck and Rhone Poulenc announced last week that they have completed the first phase of the Merial organization that was developed with the forming of Merial in 1997.&nbsp; A press release was made by Merial in London on February 18, 2000 indicating that Alan Reade would become the Executive Chairman of Merial effective February 21, 2000.&nbsp; The release further indicates that Dr. Preston and Mr. Champel will serve as consultants to Merial and Mr. Reade for a limited period of time. TheView Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/pt\/23609\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2000-02-21T18:51:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-04-14T06:59:05+00:00\" \/>\n<meta name=\"author\" content=\"Brakke Consulting\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brakke Consulting\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/23609\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/23609\/\"},\"author\":{\"name\":\"Brakke Consulting\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"headline\":\"Animal Health News &#038; Notes for February 21, 2000 &#8211; Special Edition\",\"datePublished\":\"2000-02-21T18:51:17+00:00\",\"dateModified\":\"2018-04-14T06:59:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/23609\/\"},\"wordCount\":450,\"articleSection\":[\"Newsletter\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/23609\/\",\"url\":\"https:\/\/brakkeconsulting.com\/23609\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#website\"},\"datePublished\":\"2000-02-21T18:51:17+00:00\",\"dateModified\":\"2018-04-14T06:59:05+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/23609\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/23609\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/23609\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Animal Health News &#038; Notes for February 21, 2000 &#8211; Special Edition\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\",\"name\":\"Brakke Consulting\",\"url\":\"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Not\u00edcias da Brakke Consulting","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/pt\/23609\/","og_locale":"pt_PT","og_type":"article","og_title":"News from Brakke Consulting","og_description":"SPECIAL EDITION Brakke Consulting&rsquo;s Animal Health News &amp; Notes for February 21, 2000 Copyright &copy; Brakke Consulting, Inc. (note: the regular edition of Brakke Consulting Animal Health News &amp; Notes will be published on February 25.) Company News Releases &bull;&nbsp;Merck and Aventis, joint parent companies of Merial, announced that effective February 21, 2000, Alan Reade will assume the position of executive chairman of Merial.&nbsp; The announcement was made on February 18, 2000.&nbsp; Reade was formerly the president and CEO of Rhone-Poulenc Agro for North American Operations, and is currently the leader of the Aventis CropScience post-merger integration process.&nbsp; In order to ensure a smooth transition John Preston, the previous executive chairman of Merial, and Louis Champel, the previous CEO, will serve as consultants to Merial and Alan Reade for a limited period of time. ********************************************************************* Brakke Consulting Viewpoint Merck and Rhone Poulenc announced last week that they have completed the first phase of the Merial organization that was developed with the forming of Merial in 1997.&nbsp; A press release was made by Merial in London on February 18, 2000 indicating that Alan Reade would become the Executive Chairman of Merial effective February 21, 2000.&nbsp; The release further indicates that Dr. Preston and Mr. Champel will serve as consultants to Merial and Mr. Reade for a limited period of time. TheView Full Post;","og_url":"https:\/\/brakkeconsulting.com\/pt\/23609\/","og_site_name":"Brakke Consulting Website","article_published_time":"2000-02-21T18:51:17+00:00","article_modified_time":"2018-04-14T06:59:05+00:00","author":"Brakke Consulting","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Brakke Consulting","Tempo estimado de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/23609\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/23609\/"},"author":{"name":"Brakke Consulting","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"headline":"Animal Health News &#038; Notes for February 21, 2000 &#8211; Special Edition","datePublished":"2000-02-21T18:51:17+00:00","dateModified":"2018-04-14T06:59:05+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/23609\/"},"wordCount":450,"articleSection":["Newsletter"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/23609\/","url":"https:\/\/brakkeconsulting.com\/23609\/","name":"Not\u00edcias da Brakke Consulting","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/#website"},"datePublished":"2000-02-21T18:51:17+00:00","dateModified":"2018-04-14T06:59:05+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/23609\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/23609\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/23609\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/"},{"@type":"ListItem","position":2,"name":"Animal Health News &#038; Notes for February 21, 2000 &#8211; Special Edition"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/#website","url":"https:\/\/brakkeconsulting.com\/","name":"Site da Brakke Consulting","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6","name":"Brakke Consultoria","url":"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/23609","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/comments?post=23609"}],"version-history":[{"count":1,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/23609\/revisions"}],"predecessor-version":[{"id":25078,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/23609\/revisions\/25078"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/media?parent=23609"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/categories?post=23609"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/tags?post=23609"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}